News | August 13, 2024
Ashland completes second expansion of Viatel bioresorbable polymers manufacturing and R&D lab in Ireland
This project is supported by the Irish Government through IDA Ireland
This project is supported by the Irish Government through IDA Ireland
For the 2024 outlook, sales growth is now expected to be 22-28% at CER
Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
EBITDA for Q1 FY25 is at Rs. 100 crore compared to Rs. 32 crore in the previous year
Q1FY25 Revenue from Operations grew by 15% to Rs. 177 crore
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
The comprehensive criteria encompasses evaluation of debt management, sales growth, earnings-per-share performance, as well as returns on equity
Our centers are performing as expected or even better
This accelerates the clinical-to-commercial process timeline and enables customers to develop the right molecule
The International Society of Aesthetic Plastic Surgery reported that non-surgical procedures outnumbered surgical ones globally in 2020
Subscribe To Our Newsletter & Stay Updated
